Abstract
OBJECTIVE--To determine whether postmenopausal women with cardiological syndrome X (chest pain and abnormal exercise electrocardiogram despite normal coronary angiography) exhibit disturbances in the full range of proposed components of the putative "insulin resistance syndrome". PATIENTS AND METHODS--20 postmenopausal women with syndrome X and 20 healthy controls each underwent measurement of insulin resistance (by minimal model analysis of the intravenous glucose tolerance test), lipid, lipoprotein, and apolipoprotein concentrations, a range of haemostatic variables, serum uric acid concentration, and centrality of body fat distribution (by dual energy x ray absorptiometry). RESULTS--Women with syndrome X had higher fasting triglyceride concentrations than controls (median: 1.60 v 1.02 mmol/l, P < 0.05). Concentrations of high density lipoprotein cholesterol were lower (1.33 v 1.61 mmol/l, P < 0.05) as were those of the high density lipoprotein apolipoproteins AI and AII. Insulin and C peptide responses to the intravenous glucose tolerance test were higher (27.6 v 19.8 microU/ml/min, P < 0.01; 101 v 72 pmol/ml/min, P < 0.05, respectively), and insulin sensitivity was lower (1.89 v 3.09 min/microU/ml, P < 0.05). There were, however, no significant differences between other proposed components of the insulin resistance syndrome (blood pressure, glucose tolerance, proportion of central body fat, serum uric acid concentration, and plasminogen activator inhibitor-1 activity). Antithrombin III activity was higher in women with syndrome X (121 v 113%, P < 0.01). CONCLUSIONS--Women with syndrome X tend to be insulin resistant and have lipid and lipoprotein abnormalities, but do not exhibit all characteristics of the insulin resistance syndrome. Such variation in correlated risk factors is consistent with underlying heterogeneity in the insulin resistance syndrome and cardiological syndrome X.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bergman R. N., Ider Y. Z., Bowden C. R., Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979 Jun;236(6):E667–E677. doi: 10.1152/ajpendo.1979.236.6.E667. [DOI] [PubMed] [Google Scholar]
- Björntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991 Dec;14(12):1132–1143. doi: 10.2337/diacare.14.12.1132. [DOI] [PubMed] [Google Scholar]
- Bøtker H. E., Møller N., Ovesen P., Mengel A., Schmitz O., Orskov H., Bagger J. P. Insulin resistance in microvascular angina (syndrome X) Lancet. 1993 Jul 17;342(8864):136–140. doi: 10.1016/0140-6736(93)91344-l. [DOI] [PubMed] [Google Scholar]
- Cannon R. O., 3rd, Camici P. G., Epstein S. E. Pathophysiological dilemma of syndrome X. Circulation. 1992 Mar;85(3):883–892. doi: 10.1161/01.cir.85.3.883. [DOI] [PubMed] [Google Scholar]
- Chauhan A., Petch M. C., Schofield P. M. Insulin resistance in syndrome X. Lancet. 1993 Aug 28;342(8870):554–554. [PubMed] [Google Scholar]
- Dean J. D., Jones C. J., Hutchison S. J., Peters J. R., Henderson A. H. Hyperinsulinaemia and microvascular angina ("syndrome X") Lancet. 1991 Feb 23;337(8739):456–457. [PubMed] [Google Scholar]
- Fuh M. M., Jeng C. Y., Young M. M., Sheu W. H., Chen Y. D., Reaven G. M. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metabolism. 1993 Sep;42(9):1090–1092. doi: 10.1016/0026-0495(93)90264-o. [DOI] [PubMed] [Google Scholar]
- Gidez L. I., Miller G. J., Burstein M., Slagle S., Eder H. A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res. 1982 Nov;23(8):1206–1223. [PubMed] [Google Scholar]
- Hutchison S. J., Poole-Wilson P. A., Henderson A. H. Angina with normal coronary arteries: a review. Q J Med. 1989 Aug;72(268):677–688. [PubMed] [Google Scholar]
- Jarrett R. J. In defence of insulin: a critique of syndrome X. Lancet. 1992 Aug 22;340(8817):469–471. doi: 10.1016/0140-6736(92)91781-3. [DOI] [PubMed] [Google Scholar]
- Kemp H. G., Jr Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 1973 Sep 7;32(3):375–376. doi: 10.1016/s0002-9149(73)80150-x. [DOI] [PubMed] [Google Scholar]
- Ley C. J., Lees B., Stevenson J. C. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992 May;55(5):950–954. doi: 10.1093/ajcn/55.5.950. [DOI] [PubMed] [Google Scholar]
- Meade T. W., Cooper J., Miller G. J., Howarth D. J., Stirling Y. Antithrombin III and arterial disease. Lancet. 1991 Oct 5;338(8771):850–851. doi: 10.1016/0140-6736(91)91503-m. [DOI] [PubMed] [Google Scholar]
- Moller D. E., Flier J. S. Insulin resistance--mechanisms, syndromes, and implications. N Engl J Med. 1991 Sep 26;325(13):938–948. doi: 10.1056/NEJM199109263251307. [DOI] [PubMed] [Google Scholar]
- Mount J. N., Kearney E. M., Rosseneu M., Slavin B. M. Immunoturbidimetric assays for serum apolipoproteins A1 and B using Cobas Bio centrifugal analyser. J Clin Pathol. 1988 Apr;41(4):471–474. doi: 10.1136/jcp.41.4.471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
- Reaven G. M. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med. 1993;44:121–131. doi: 10.1146/annurev.me.44.020193.001005. [DOI] [PubMed] [Google Scholar]
- Saeed B. T., Bartlett W. A., Murray R. G., Jones A. F., Beattie J. M. Insulin resistance in syndrome X. Lancet. 1993 Aug 28;342(8870):555–555. [PubMed] [Google Scholar]
- Swan J. W., Walton C., Godsland I. F. Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. Clin Sci (Lond) 1994 Mar;86(3):317–322. doi: 10.1042/cs0860317. [DOI] [PubMed] [Google Scholar]
- Swan J. W., Walton C., Godsland I. F., Crook D., Oliver M. F., Stevenson J. C. Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J. 1994 Jan;71(1):41–44. doi: 10.1136/hrt.71.1.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969 Mar;22(2):158–161. doi: 10.1136/jcp.22.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vølund A., Polonsky K. S., Bergman R. N. Calculated pattern of intraportal insulin appearance without independent assessment of C-peptide kinetics. Diabetes. 1987 Oct;36(10):1195–1202. doi: 10.2337/diab.36.10.1195. [DOI] [PubMed] [Google Scholar]
- Walton C., Godsland I. F., Proudler A. J., Felton C., Wynn V. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol. 1992 May;262(5 Pt 1):E755–E762. doi: 10.1152/ajpendo.1992.262.5.E755. [DOI] [PubMed] [Google Scholar]
- Warnick G. R., Albers J. J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res. 1978 Jan;19(1):65–76. [PubMed] [Google Scholar]
- Watanabe R. M., Volund A., Roy S., Bergman R. N. Prehepatic beta-cell secretion during the intravenous glucose tolerance test in humans: application of a combined model of insulin and C-peptide kinetics. J Clin Endocrinol Metab. 1989 Oct;69(4):790–797. doi: 10.1210/jcem-69-4-790. [DOI] [PubMed] [Google Scholar]
- Wenger N. K., Speroff L., Packard B. Cardiovascular health and disease in women. N Engl J Med. 1993 Jul 22;329(4):247–256. doi: 10.1056/NEJM199307223290406. [DOI] [PubMed] [Google Scholar]
